{"id":1762,"date":"2025-09-11T11:05:41","date_gmt":"2025-09-11T11:05:41","guid":{"rendered":"https:\/\/www.anuhpharma.com\/investor-relations\/?page_id=1762"},"modified":"2025-09-12T07:21:23","modified_gmt":"2025-09-12T07:21:23","slug":"saksham-niveshak-100-days-campaign","status":"publish","type":"page","link":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/","title":{"rendered":"Saksham Niveshak \u2013 100 Days Campaign"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1762\" class=\"elementor elementor-1762\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-013a5a2 overlap-wrapper e-flex e-con-boxed e-con e-parent\" data-id=\"013a5a2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e07e6c7 elementor-widget elementor-widget-text-editor\" data-id=\"e07e6c7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>FROM 28TH JULY 2025 TO 6TH NOVEMBER 2025.<\/strong><\/p><p>Pursuant to the directions issued by the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA), vide Circular dated 16th July 2025, shareholders are hereby notified about the launch of the \u201cSaksham Niveshak \u2013 100 Days Campaign\u201d, scheduled from 28th July, 2025 to 6th November, 2025.<\/p><p>This initiative aims to create awareness amongst investors and facilitate the resolution of pending issues relating to unclaimed dividends and shares, updation of KYC and nomination details, and enable investors to claim their rightful entitlements.<\/p><p>In accordance with the provisions of the Companies Act, 2013<\/p><ul><li>Section 124(2): Companies must publish details of unpaid dividends on their websites within 90 days of transfer to the Unpaid Dividend Account.<\/li><li>Section 124(5): Dividends remaining unpaid\/unclaimed for 7 years are mandatorily transferred to the IEPF.<\/li><li>Section 124(6): Shares underlying such unclaimed dividends must also be transferred to the IEPF Demat Account.<\/li><\/ul><p>Shareholders who have not claimed their dividends or whose shares\/dividends are liable to be transferred to IEPF are requested to:<\/p><p>1. Visit the IEPF website <a href=\"http:\/\/www.iepf.gov.in\" target=\"_blank\" rel=\"noopener\">www.iepf.gov.in<\/a> for claim filing procedures. <br \/>2. Visit the Company\u2019s website <a href=\"http:\/\/www.anuhpharma.com\" target=\"_blank\" rel=\"noopener\">www.anuhpharma.com<\/a> under the Investor Relations section for details of unpaid dividends and shares liable for transfer.<\/p><p>Further, pursuant to SEBI Circulars:<\/p><ul><li>SEBI\/HO\/MIRSD\/POD-1\/P\/CIR\/2023\/70 dated 17 May 2023, and<\/li><li>SEBI\/HO\/MIRSD\/MIRSD_RTAMB\/P\/CIR\/2021\/687 dated 16 December 2021,<\/li><\/ul><p>it is mandatory for all investors to update their PAN, KYC, Nomination, Bank details, Contact details (postal address, mobile number), and Demat account linking (where applicable) to avoid freezing of folios and to ensure seamless processing of corporate benefits.<\/p><p>The dividends on shares are payable only in electronic mode i.e. dividends will be credited directly to the bank accounts of the shareholders. Accordingly, shareholders are requested to:<\/p><p>Download and submit the following forms from website of the Bigshare Services Private Limited, Registrar and Share Transfer Agent (our RTA) at <a href=\"https:\/\/www.bigshareonline.com\/resources-sebi_circular.aspx#parentHorizontalTab3\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bigshareonline.com\/resources-sebi_circular.aspx#parentHorizontalTab3<\/a> Registrar and Transfer Agent (RTA):<\/p><ul><li>Form ISR-1: Duly filled and signed, with self-attested KYC documents.<\/li><li>Form ISR-2: Duly filled and signed, with banker\u2019s attestation of signature and original cancelled cheque (with name printed) or self-attested bank passbook\/statement.<\/li><li>Form SH-13: For adding a nominee.<\/li><li>Form ISR-3: If you wish to opt out of nomination.<\/li><\/ul><p>Please fill in and deliver the forms to:<br \/>Bigshare Services Private Limited<br \/>Office No S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre,<br \/>Mahakali Caves Road, Andheri (East), Mumbai 400093<br \/>Mail Id: <a href=\"mailto:investor@bigshareonline.com\">investor@bigshareonline.com<\/a><br \/>Contact No.: <a href=\"tel:022-6263 8200\">022-6263 8200<\/a> \/ <a href=\"tel:08069219060\">08069219060<\/a> \/ <a href=\"tel:08069219061\">08069219061<\/a> \/ <a href=\"tel:08069219065\">08069219065<\/a><\/p><p>Mode of dispatch:<\/p><ul><li>By post: Physical copies, self-attested and dated.<\/li><li>By email: From your registered email ID, with digitally signed documents (for joint holders, first holder must sign). Email to <a href=\"mailto:investor@bigshareonline.com\">investor@bigshareonline.com<\/a><\/li><\/ul><p>This campaign is intended to facilitate shareholders in updating their details and claiming their rightful entitlements.<\/p><p>Shareholders holding shares in dematerialized form, are requested to contact their Depository Participants to update their details.<\/p><p>Kindly submit your documents on or before November 6, 2025.<\/p><p>For any assistance or queries, shareholders may contact RTA on <a href=\"mailto:investor@bigshareonline.com\">investor@bigshareonline.com<\/a> or e-mail to <a href=\"mailto:anuh@sk1932.com\">anuh@sk1932.com<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>FROM 28TH JULY 2025 TO 6TH NOVEMBER 2025. Pursuant to the directions issued by the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA), vide Circular dated 16th July 2025, shareholders are hereby notified about the launch of the \u201cSaksham Niveshak \u2013 100 Days Campaign\u201d, scheduled from 28th July, 2025 to 6th [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1762","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma\" \/>\n<meta property=\"og:description\" content=\"FROM 28TH JULY 2025 TO 6TH NOVEMBER 2025. Pursuant to the directions issued by the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA), vide Circular dated 16th July 2025, shareholders are hereby notified about the launch of the \u201cSaksham Niveshak \u2013 100 Days Campaign\u201d, scheduled from 28th July, 2025 to 6th [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/\" \/>\n<meta property=\"og:site_name\" content=\"Anuh Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-12T07:21:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/saksham-niveshak-100-days-campaign\\\/\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/saksham-niveshak-100-days-campaign\\\/\",\"name\":\"Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#website\"},\"datePublished\":\"2025-09-11T11:05:41+00:00\",\"dateModified\":\"2025-09-12T07:21:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/saksham-niveshak-100-days-campaign\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/saksham-niveshak-100-days-campaign\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/saksham-niveshak-100-days-campaign\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Investor Relations\",\"item\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Saksham Niveshak \u2013 100 Days Campaign\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#website\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\",\"name\":\"Anuh Pharma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#organization\",\"name\":\"Anuh Pharma Limited\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/anuh-pharma-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/anuh-pharma-logo.png\",\"width\":197,\"height\":71,\"caption\":\"Anuh Pharma Limited\"},\"image\":{\"@id\":\"https:\\\/\\\/www.anuhpharma.com\\\/investor-relations\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/anuhpharma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/","og_locale":"en_US","og_type":"article","og_title":"Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma","og_description":"FROM 28TH JULY 2025 TO 6TH NOVEMBER 2025. Pursuant to the directions issued by the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs (MCA), vide Circular dated 16th July 2025, shareholders are hereby notified about the launch of the \u201cSaksham Niveshak \u2013 100 Days Campaign\u201d, scheduled from 28th July, 2025 to 6th [&hellip;]","og_url":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/","og_site_name":"Anuh Pharma","article_modified_time":"2025-09-12T07:21:23+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/","url":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/","name":"Saksham Niveshak \u2013 100 Days Campaign - Anuh Pharma","isPartOf":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#website"},"datePublished":"2025-09-11T11:05:41+00:00","dateModified":"2025-09-12T07:21:23+00:00","breadcrumb":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/saksham-niveshak-100-days-campaign\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Investor Relations","item":"https:\/\/www.anuhpharma.com\/investor-relations\/"},{"@type":"ListItem","position":2,"name":"Saksham Niveshak \u2013 100 Days Campaign"}]},{"@type":"WebSite","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#website","url":"https:\/\/www.anuhpharma.com\/investor-relations\/","name":"Anuh Pharma","description":"","publisher":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anuhpharma.com\/investor-relations\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#organization","name":"Anuh Pharma Limited","url":"https:\/\/www.anuhpharma.com\/investor-relations\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#\/schema\/logo\/image\/","url":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-content\/uploads\/2024\/02\/anuh-pharma-logo.png","contentUrl":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-content\/uploads\/2024\/02\/anuh-pharma-logo.png","width":197,"height":71,"caption":"Anuh Pharma Limited"},"image":{"@id":"https:\/\/www.anuhpharma.com\/investor-relations\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/anuhpharma"]}]}},"_links":{"self":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/pages\/1762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/comments?post=1762"}],"version-history":[{"count":16,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/pages\/1762\/revisions"}],"predecessor-version":[{"id":2006,"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/pages\/1762\/revisions\/2006"}],"wp:attachment":[{"href":"https:\/\/www.anuhpharma.com\/investor-relations\/wp-json\/wp\/v2\/media?parent=1762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}